Sale!

Sermorelin

Name: Sermorelin
Brand: Peptide Titans
SKU: 1156
Availability: InStock

Price range: $249.00 through $429.00

Sermorelin is a synthetic peptide analog of growth hormone–releasing hormone (GHRH 1–29), studied for its ability to stimulate endogenous growth hormone release via activation of pituitary GHRH receptors. In research settings, it’s explored for its effects on IGF-1 signaling, metabolic regulation, and endocrine-related pathways. Intended for research use only, not for human or veterinary use.

Clear

Description
Additional information

Molecular Characteristics

Complete Specifications

CAS Registry Number: 86168-78-7
PubChem CID: Not available
Peptide Classification: Synthetic 29-amino-acid growth hormone–releasing hormone (GHRH) fragment
Molecular Formula: C₁₄₉H₂₄₆N₄₄O₄₂
Molecular Weight: ~3,357.9 Da

Structural Composition

Amino Acid Sequence:
Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg
Length: 29 amino acids

Physical Properties

Appearance: White to off-white lyophilized powder
Solubility: Water, bacteriostatic water, buffered aqueous solutions (e.g., PBS)

Structural & Stability Notes

Sermorelin is a synthetic 29-amino-acid peptide corresponding to the biologically active N-terminal fragment of growth hormone–releasing hormone (GHRH 1–29). Its mid-length structure provides moderate conformational stability while remaining susceptible to enzymatic degradation in biological systems. Lyophilized storage under cold, dry conditions is recommended to maintain stability. Protection from moisture, light exposure, and repeated freeze–thaw cycles helps preserve structural integrity and maintain analytical consistency during laboratory research applications.

Research Applications

Growth Hormone–Releasing Hormone (GHRH) Signaling Research

Sermorelin is utilized as a synthetic analog of growth hormone–releasing hormone (GHRH 1–29) in research studies examining pituitary signaling and growth hormone regulatory pathways. Laboratory investigations focus on its role in:

GHRH Receptor Activation Models: Investigation of receptor binding dynamics and cAMP-mediated intracellular signaling cascades
Adenylate Cyclase and PKA Studies: Evaluation of second messenger amplification following receptor stimulation
Pituitary Somatotroph Research: Analysis of intracellular pathways regulating growth hormone secretion dynamics
Receptor Desensitization Models: Examination of adaptive responsiveness and signaling duration under repeated stimulation
Peptide Stability Studies: Investigation of structural persistence and degradation kinetics in laboratory systems

Experimental protocols commonly employ receptor-binding assays, pituitary cell cultures, and intracellular signaling analyses to characterize Sermorelin-mediated endocrine responses.

Growth Hormone Axis and Endocrine Regulation Research

Sermorelin has been examined in research contexts involving growth hormone regulatory networks and hypothalamic–pituitary signaling systems. Key areas of investigation include:

GH Pulse Secretion Models: Evaluation of temporal hormone release patterns under controlled stimulation conditions
Hypothalamic Interaction Studies: Investigation of signaling pathways involving somatostatin and feedback regulation
IGF-1 Axis Research: Analysis of downstream signaling cascades associated with growth hormone–mediated pathways
Endocrine Feedback Models: Research into coordinated regulatory loops within growth hormone systems
Receptor Sensitivity Studies: Examination of adaptive responsiveness within GHRH receptor systems

These studies utilize hormone quantification assays, transcription factor profiling, and intracellular kinase activation analyses to evaluate endocrine signaling outcomes.

Metabolic and Lipid Signaling Research

Sermorelin has also been explored in research models examining metabolic regulation and lipid-associated intracellular signaling pathways, including:

Adipocyte Signaling Models: Evaluation of intracellular cascades influencing lipid-associated metabolic regulation
AMPK Pathway Studies: Investigation of energy-sensing signaling mechanisms
Glucose Homeostasis Research: Analysis of intracellular pathways associated with metabolic balance
Hepatic Signaling Models: Examination of growth hormone–mediated liver regulatory pathways

Laboratory protocols assess metabolic enzyme activity, transcriptional markers, and intracellular signaling cascades using biochemical and molecular techniques.

Cellular Signaling and Endocrine Network Research

Additional research applications explore Sermorelin’s influence on intracellular regulatory systems involved in growth hormone axis coordination and systemic endocrine balance, including:

MAPK and ERK Pathway Studies: Investigation of downstream cascades associated with GHRH receptor activation
Gene Expression Profiling: Analysis of transcriptional responses linked to endocrine regulatory systems
Receptor Modulation Research: Examination of adaptive signaling modulation within GHRH receptor systems
Integrated Hormonal Network Models: Analysis of coordinated signaling systems maintaining endocrine equilibrium

Research in this domain focuses on understanding how Sermorelin influences GHRH receptor–mediated signaling pathways, growth hormone regulatory systems, and metabolic-associated intracellular responses under controlled experimental conditions.

Laboratory Handling and Storage Protocols

Lyophilized Powder Storage

Store at –20°C to –80°C in the original, sealed vial
Protect from light exposure and moisture
A desiccated storage environment is recommended
Stability data suggests extended stability when stored at −20 °C or below.

Reconstitution Guidelines

Reconstitute using sterile water, bacteriostatic water (0.9% benzyl alcohol), or an appropriate laboratory buffer
Introduce solvent slowly along the vial wall to minimize foaming
Mix using gentle swirling; avoid vigorous agitation or shaking
Allow complete dissolution prior to use (typically 1–2 minutes)
Ensure the final solution is within a physiologically neutral pH range appropriate for laboratory use

Reconstituted Solution Storage

Short-term storage: Up to 7 days at 4°C
Long-term storage: Store at –20°C in aliquots
Use single-use aliquots to preserve peptide integrity
Minimize freeze–thaw cycles; single-use aliquots are strongly recommended

Stability Characteristics

Sermorelin is a synthetic peptide research compound that demonstrates stable handling characteristics when managed according to standard peptide laboratory protocols. Proper cold storage of the lyophilized material, protection from light, careful reconstitution, and minimized freeze–thaw exposure help preserve structural integrity and solubility. When handled appropriately, Sermorelin supports consistent use in in vitro and analytical research applications.

Frequently Asked Questions

What is Sermorelin?

Sermorelin is a synthetic peptide analog of the active portion of GHRH. It is used in research to investigate growth hormone regulatory pathways and endocrine signaling mechanisms.

What is Sermorelin commonly researched for?

In laboratory and preclinical models, Sermorelin is studied for:

GHRH receptor activation
Growth hormone release signaling pathways
IGF-1 axis investigations
Hypothalamic–pituitary axis regulation models
Endocrine and metabolic pathway research

All applications are exploratory and conducted in controlled research environments.

How does Sermorelin differ from Tesamorelin?

Both are GHRH analogs studied in endocrine research. Sermorelin represents the 1–29 active fragment of GHRH, while Tesamorelin is a modified analog with structural changes that may influence stability and signaling characteristics in experimental models.

Is Sermorelin the same as growth hormone (GH)?

No. Sermorelin stimulates the GHRH receptor, which influences endogenous growth hormone signaling. It is not growth hormone itself.

Is Sermorelin a peptide?

Yes. Sermorelin is a synthetic peptide composed of 29 amino acids.

How is Sermorelin supplied?

Sermorelin is typically supplied as a lyophilized (freeze-dried) powder in sealed research vials to preserve stability during storage and shipment.

How should unreconstituted Sermorelin be stored?

Lyophilized Sermorelin should be stored:

Long-term: −20 °C to −80 °C
Short-term: 2–8 °C

Keep vials sealed and protected from light and moisture until use.

How should reconstituted Sermorelin be handled and stored?

Once reconstituted:

Store at 2–8 °C for short-term laboratory use
For extended storage, aliquot and freeze at −20 °C or below
Minimize freeze–thaw cycles using single-use aliquots
Gently swirl to mix; avoid vigorous agitation

Does Sermorelin require a Certificate of Analysis (COA)?

Yes. A Certificate of Analysis (COA) should be available for each batch, verifying peptide identity, purity, and analytical testing results to ensure research quality and traceability.

Is Sermorelin FDA-approved?

When sold as a research compound, Sermorelin is not FDA-approved for diagnostic, therapeutic, or consumption purposes and must be marketed strictly for laboratory research use.

⚠️ Research Use Only

This product is not for human consumption. It is sold strictly for research and educational purposes and is not intended to diagnose, treat, cure, or prevent any disease.

Any clinical data or research information referenced on this page is derived from peer-reviewed scientific literature and official publications. This information is provided for educational reference only and does not constitute medical advice or product claims.

By purchasing this product, you acknowledge that you are a qualified researcher and agree to use it in full compliance with all applicable laws and regulations.